MIM
Monashee Investment Management Portfolio holdings
AUM
$190M
This Quarter Return
+101.57%
1 Year Return
+42.84%
3 Year Return
+185.9%
5 Year Return
+237.5%
10 Year Return
+2,730.86%
AUM
$669M
AUM Growth
+$669M
(+258%)
Cap. Flow
+$479M
Cap. Flow
% of AUM
71.55%
Top 10 Holdings %
Top 10 Hldgs %
31.65%
Holding
214
New
153
Increased
2
Reduced
1
Closed
16
Top Buys
| 1 |
NKLA
Nikola Corporation Common Stock
NKLA
|
$67.5M |
| 2 |
T-Mobile US
TMUS
|
$32.3M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$24.9M |
| 4 |
DraftKings
DKNG
|
$20.8M |
| 5 |
Aptiv
APTV
|
$13.2M |
Top Sells
Sector Composition
| 1 | Healthcare | 32.46% |
| 2 | Consumer Discretionary | 20.31% |
| 3 | Communication Services | 8.34% |
| 4 | Technology | 8.26% |
| 5 | Financials | 6.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
IDEAYA Biosciences
IDYA
$2.27B
| $1.99M | 0.3% |
+140,000
| New | +$1.99M |
|
102
OrthoPediatrics
KIDS
$516M
| $1.97M | 0.29% |
+45,000
| New | +$1.97M |
|
|
RP
103
DELISTED
RealPage, Inc.
RP
| $1.95M | 0.29% |
+30,000
| New | +$1.95M |
|
104
Repare Therapeutics
RPTX
$73.5M
| $1.86M | 0.28% |
+60,000
| New | +$1.86M |
|
105
Jasper Therapeutics
JSPR
$45.3M
| $1.79M | 0.27% |
175,000
| – | – |
|
106
Chefs' Warehouse
CHEF
$2.64B
| $1.77M | 0.26% |
+130,000
| New | +$1.77M |
|
|
AMTI
107
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
| $1.76M | 0.26% |
+70,000
| New | +$1.76M |
|
108
VYNE Therapeutics
VYNE
$8.17M
| $1.74M | 0.26% |
+1,005,000
| New | +$1.74M |
|
109
Palomar
PLMR
$3.31B
| $1.72M | 0.26% |
+20,000
| New | +$1.72M |
|
110
CommScope
COMM
$3.65B
| $1.67M | 0.25% |
+200,000
| New | +$1.67M |
|
111
Twist Bioscience
TWST
$1.61B
| $1.63M | 0.24% |
+36,000
| New | +$1.63M |
|
|
DMTK
112
DELISTED
DermTech, Inc. Common Stock
DMTK
| $1.58M | 0.24% |
119,049
+71,407
| +150% | +$945K |
|
113
BeyondSpring
BYSI
$73.4M
| $1.51M | 0.23% |
+100,000
| New | +$1.51M |
|
|
RCOR
114
DELISTED
Renovacor, Inc.
RCOR
| $1.49M | 0.22% |
+150,000
| New | +$1.49M |
|
115
Shift4
FOUR
$6.09B
| $1.42M | 0.21% |
+40,000
| New | +$1.42M |
|
116
Vicor
VICR
$2.25B
| $1.4M | 0.21% |
+19,500
| New | +$1.4M |
|
117
Replimune Group
REPL
$475M
| $1.39M | 0.21% |
+56,000
| New | +$1.39M |
|
|
GLUU
118
DELISTED
Glu Mobile Inc.
GLUU
| $1.39M | 0.21% |
+150,000
| New | +$1.39M |
|
119
Cidara Therapeutics
CDTX
$1.62B
| $1.36M | 0.2% |
369,099
| – | – |
|
120
Katapult Holdings
KPLT
$87.1M
| $1.35M | 0.2% |
135,938
| – | – |
|
|
AVEO
121
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $1.29M | 0.19% |
+250,000
| New | +$1.29M |
|
|
HECCU
122
DELISTED
Hudson Executive Investment Corp. Units
HECCU
| $1.28M | 0.19% |
+125,000
| New | +$1.28M |
|
|
AXLA
123
DELISTED
Axcella Health Inc. Common Stock
AXLA
| $1.24M | 0.19% |
+225,000
| New | +$1.24M |
|
|
MTEM
124
DELISTED
Molecular Templates, Inc.
MTEM
| $1.24M | 0.19% |
90,000
-94,400
| -51% | -$1.3M |
|
125
Virtu Financial
VIRT
$3.51B
| $1.18M | 0.18% |
+50,000
| New | +$1.18M |
|